Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan ...

FDA Recall #D-0327-2019 — Class II — December 4, 2018

Recall #D-0327-2019 Date: December 4, 2018 Classification: Class II Status: Ongoing

Product Description

Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.

Reason for Recall

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Recalling Firm

Mylan Laboratories Limited, (Nashik FDF) — Sinnar, Nashik District, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

129,754 HDPE bottles

Distribution

Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Code Information

Lot Numbers: 3063783 3063784 3063785 3064092 3064093 3064094 3070349 3070350 3070351 3070352 3070353 3070354 3079030 3079031 3079032 3079033 3080011 3080224 3081498 3081500 3087126 3088476

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated